88.64
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$89.91
Aprire:
$89.79
Volume 24 ore:
2.44M
Relative Volume:
1.52
Capitalizzazione di mercato:
$21.97B
Reddito:
$7.83B
Utile/perdita netta:
$825.20M
Rapporto P/E:
21.58
EPS:
4.1067
Flusso di cassa netto:
$1.05B
1 W Prestazione:
-0.10%
1M Prestazione:
-13.03%
6M Prestazione:
-8.57%
1 anno Prestazione:
-21.24%
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Nome
Zimmer Biomet Holdings Inc
Settore
Industria
Telefono
(574) 267-6131
Indirizzo
345 EAST MAIN STREET, WARSAW, IN
Confronta ZBH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
ZBH
Zimmer Biomet Holdings Inc
|
88.64 | 17.82B | 7.83B | 825.20M | 1.05B | 4.1067 |
|
ABT
Abbott Laboratories
|
130.03 | 227.08B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
360.13 | 138.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
96.28 | 122.96B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
BSX
Boston Scientific Corp
|
101.76 | 152.23B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
GEHC
Ge Healthcare Technologies Inc
|
70.63 | 33.32B | 20.25B | 2.29B | 1.40B | 4.8366 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-09-18 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-07-15 | Aggiornamento | Roth Capital | Neutral → Buy |
| 2024-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Peer Perform |
| 2024-07-01 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-21 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Iniziato | ROTH MKM | Neutral |
| 2023-08-28 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-05-03 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Aggiornamento | Jefferies | Underperform → Hold |
| 2023-03-29 | Iniziato | UBS | Sell |
| 2023-03-10 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Underweight |
| 2022-10-12 | Iniziato | Jefferies | Underperform |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-04-01 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Underperform |
| 2022-03-02 | Downgrade | Loop Capital | Buy → Hold |
| 2022-02-08 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Reiterato | Citigroup | Buy |
| 2022-02-08 | Reiterato | Deutsche Bank | Hold |
| 2022-02-08 | Reiterato | JMP Securities | Mkt Outperform |
| 2022-02-08 | Reiterato | JP Morgan | Neutral |
| 2022-02-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Reiterato | Stifel | Buy |
| 2022-02-08 | Reiterato | Truist | Buy |
| 2022-02-08 | Reiterato | UBS | Neutral |
| 2022-02-08 | Reiterato | Wells Fargo | Underweight |
| 2022-02-02 | Downgrade | UBS | Buy → Neutral |
| 2022-01-19 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Downgrade | Mizuho | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Downgrade | Needham | Strong Buy → Buy |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-11-23 | Downgrade | Argus | Buy → Hold |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-09 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Reiterato | Needham | Strong Buy |
| 2020-10-20 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-08-05 | Reiterato | Needham | Strong Buy |
| 2020-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-09 | Downgrade | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Reiterato | Needham | Strong Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-07 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2019-09-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Aggiornamento | Argus | Hold → Buy |
| 2019-07-30 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Aggiornamento | Needham | Buy → Strong Buy |
Mostra tutto
Zimmer Biomet Holdings Inc Borsa (ZBH) Ultime notizie
Zimmer Biomet Receives U.S. FDA Clearance for Enhanced Version of ROSA® Knee Robotic Technology - InkFreeNews.com
Zimmer Biomet Holdings, Inc. $ZBH Shares Sold by Forsta AP Fonden - MarketBeat
Geode Capital Management LLC Has $465.48 Million Stock Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings, Inc. $ZBH Shares Sold by PNC Financial Services Group Inc. - MarketBeat
Should I buy Zimmer Biomet Holdings Inc. stock before earnings seasonPortfolio Growth Summary & Daily Growth Stock Tips - newser.com
Zimmer Biomet secures FDA approval for ROSA Knee with OptimiZe system - Medical Device Network
Why Zimmer Biomet Holdings Inc. (ZIM) stock could be next leader - newser.com
Is Zimmer Biomet Holdings Inc. (ZIM) stock positioned for secular growthProfit Target & Intraday High Probability Setup Alerts - newser.com
Strategies to average down on Zimmer Biomet Holdings Inc.July 2025 Reactions & High Accuracy Trade Signal Alerts - newser.com
Why analysts recommend Zimmer Biomet Holdings Inc. (ZIM) stockWeekly Trend Recap & AI Driven Price Predictions - newser.com
Tools to monitor Zimmer Biomet Holdings Inc. recovery probabilityJuly 2025 EndofMonth & Reliable Trade Execution Plans - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Zimmer Biomet Holdings, Inc. (ZBH) And Encourages Investors to Connect - ACCESS Newswire
ProShare Advisors LLC Buys 3,691 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
How Zimmer Biomet Holdings Inc. stock performs in easing cyclesEarnings Summary Report & Community Supported Trade Ideas - newser.com
Savant Capital LLC Grows Stock Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Can Zimmer Biomet Holdings Inc. (ZIM) stock sustain free cash flowGDP Growth & Weekly Top Gainers Trade List - newser.com
Why Zimmer Biomet Holdings Inc. stock is recommended by analystsWeekly Loss Report & Low Drawdown Investment Ideas - newser.com
Published on: 2025-11-15 17:17:39 - newser.com
Chart overlay techniques for tracking Zimmer Biomet Holdings Inc.Weekly Stock Report & Risk Managed Investment Strategies - newser.com
Grandfield & Dodd LLC Sells 7,500 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Calamos Advisors LLC Sells 30,000 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
ABN Amro Investment Solutions Acquires Shares of 34,880 Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Why Zimmer Biomet Holdings Inc. stock could see breakout soon - newser.com
Zimmer Biomet receives FDA clearance for enhanced knee surgery robot By Investing.com - Investing.com Nigeria
There May Be Some Bright Spots In Zimmer Biomet Holdings' (NYSE:ZBH) Earnings - simplywall.st
We Think You Can Look Beyond Zimmer Biomet Holdings' (NYSE:ZBH) Lackluster Earnings - 富途牛牛
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term - Yahoo Finance
M&G PLC Buys 16,389 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet receives FDA clearance for enhanced knee surgery robot - Investing.com India
Zimmer Biomet Receives 510(k) Clearance for Rosa Knee with OptimiZe - MarketScreener
Zimmer Biomet (ZBH) Achieves FDA Clearance for Advanced ROSA Kne - GuruFocus
FDA clears enhanced version of Zimmer Biomet Rosa Knee surgical robot system - MassDevice
Boston Partners Cuts Stock Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Can Zimmer Biomet Holdings Inc. (ZIM) stock sustain revenue momentum - newser.com
Will Zimmer Biomet Holdings Inc. stock sustain high P E ratiosMarket Sentiment Summary & Smart Investment Allocation Tips - newser.com
Securities Fraud Investigation Into Zimmer Biomet Holdings, Inc. (ZBH) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm - The Globe and Mail
Zimmer Biomet Holdings, Inc. (ZBH) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - The Globe and Mail
Ongoing Investigation into Zimmer Biomet Holdings, Inc. (ZBH): Contact Levi & Korsinsky About Potential Fraud - ACCESS Newswire
VeraBank N.A. Takes $364,000 Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Midwest Trust Co Purchases New Shares in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Securities Fraud Investigation Into Zimmer Biomet Holdings, Inc. (ZBH) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - The Globe and Mail
Zimmer Biomet Holdings Inc Azioni (ZBH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):